Ocular Pharmacology and Therapeutics Conference

眼部药理学和治疗会议

• 批准号: 8837851
• 负责人: W Daniel Stamer
• 金额: $ 2.5万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-12-01 至 2015-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8837851
• 关键词: Academia; Address; Area; Award; Basic Science; Blood flow; Caring; Clinical Research; Collaborations; Creativeness; Devices; Diagnosis; Disease; Doctor of Philosophy; Drug Delivery Systems; Environment; Ethnic group; Evaluation; Eye; Eye diseases; Feedback; Fellowship; Fostering; Funding; Future; Gene Mutation; Glaucoma; Goals; Immunology; Individual; Industry; International; Ischemia; Knowledge; Lead; Mind; Modification; Nature; Ophthalmologist; Participant; Pharmaceutical Preparations; Pharmacologic Substance; Pharmacology; Recording of previous events; Recruitment Activity; Research; Research Personnel; Resources; Retinal; Scientist; South Carolina; Students; Technology; Therapeutic; Time; Translational Research; Translations; Travel; Underrepresented Minority; Universities; Vision; Vision research; Woman; Work; age effect; base; career; career development; direct application; drug development; drug discovery; educational atmosphere; interest; lectures; meetings; new technology; next generation; novel; novel strategies; novel therapeutic intervention; novel therapeutics; ocular surface; posters; pre-doctoral; processing speed; professor; programs; public health relevance; response; social; symposium; technology development; unpublished works

 DESCRIPTION (provided by applicant): This proposal seeks support for the XII Biennial Conference of the Association for Ocular Pharmacology and Therapeutics (AOPT) to be held February 26th - March 1st, 2015 in Charleston, SC. As with the previous eleven meetings, the goal of AOPT 2015 is to bring together basic scientists, clinicians, students and fellows for presentations and in-depth discussions on new approaches for treating sight-threatening eye diseases. Selection of each of the scientific sessions was based on identification of those ocular fields making important advances that will lead to new therapeutics. We have recruited experts and leaders in these respective areas to chair and program these scientific sessions. In addition to a keynote lecture by Professor Palczewski, we identified ten exciting topics for inclusion in our conference. Additionally, a specific goal of the conference is to increase student and junior investigator participation with travel awards and a featured 11th platform session for young scientists. AOPT has an established history for promoting diversity, and the speakers that are selected represent a diverse group of scientists including women and underrepresented individuals. The Specific Aims of the XII Association for Ocular Pharmacology and Therapeutics Conference are: 1. to enhance the emerging careers of 20 young investigators (including women and underrepresented minorities) in ocular therapeutics by providing travel awards. 2. To provide a forum for dissemination of the most recent advances in the state of knowledge on novel therapeutic approaches to ocular disorders and disease. 3. To create an environment that will facilitate the exchange of novel ideas among basic and clinician scientists and generate the opportunity for vision scientists of all ethnic groups and social backgrounds to meet and establish research collaborations. 4. To bring together scientists working in academia and industry with the goal of expediting the delivery of novel therapeutics to those suffering from ocular diseases or disorders. We anticipate that this meeting will provide useful information on recent advances in ocular diseases and will serve as an important resource for those involved in the translation of these findings into suitable therapeutics. This conference will also provide new opportunities, avenues for new discovery, and a forum to develop potential collaborations among the attendees. The requested funds will support the travel, accommodation and registration of 10 students (pre- and postdoctoral) and 10 junior investigators who otherwise would not have the resources to attend this focused meeting.

 描述（由申请提供）：该提案寻求对将于2月26日至2015年3月1日在南卡罗来纳州查尔斯顿举行的眼科药理学和治疗学协会（AOPT）的XII双年展的支持。与前11次会议一样，AOPT 2015的目标是将基础科学家，临床医生，学生和研究员汇集起来，以进行有关治疗视力危及视力疾病的新方法的介绍和深入讨论。每个科学课程的选择都是基于对那些眼球领域的识别，从而取得了重要的进步，这将导致新的治疗疗法。我们已经招募了这些相对领域的专家和领导者，以主持和编程这些科学会议。除了Palczewski教授的主题演讲外，我们还确定了十个令人兴奋的主题，以列入会议。此外，该会议的一个具体目标是通过旅行奖和为年轻科学家举办的第11届平台会议来增加学生和初级调查员的参与。 AOPT具有促进多样性的既定历史，而被选中的演讲者代表了包括妇女和代表性不足的人在内的一群科学家。 XII眼药理学和治疗学协会的具体目的是：1。通过提供旅行奖，可以在眼部治疗中增强眼科治疗中20名年轻研究者（包括妇女和代表性不足的少数群体）的新兴职业。 2。提供一个论坛来传播有关眼部疾病和疾病的新型治疗方法的知识状态的最新进展。 3。创造一个环境，该环境将促进基础和临床科学家之间的新思想交流，并为所有种族群体的视觉科学家和社会背景提供机会，以满足和建立研究合作。 4。将在学术界和行业工作的科学家汇集在一起​​，以加快对眼部疾病或疾病患者的那些新型疗法的加快。我们预计，这次会议将提供有关眼部疾病最新进展的有用信息，并将成为参与这些发现转化为合适疗法的人们的重要资源。这次会议还将提供新的 机会，新发现的途径以及一个论坛，以发展与会者之间的潜在合作。所请求的资金将支持10名学生（预科和博士后）和10名初级调查人员的旅行，住宿和注册，否则他们将没有资源参加这次专注的会议。